Gordana Kocic

Prof. Dr. Gordana Kocic

Medicinski Fakultet Univerzitet u Nisu
+1
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AŠAndrija Šmelcerović
Andrija Šmelcerović
KTKatarina Tomović
Katarina Tomović
ŽŠŽaklina Šmelcerović
Žaklina Šmelcerović
ŽPŽivomir Petronijević
Živomir Petronijević
Gordana KocicGordana Kocic
Gordana Kocic
MAMarko Anderluh
Marko Anderluh

1 January 2008 in Journal of Radiation Research
Verified
Journal Article
Open access
PDF file
DSDušan Sokolović
Dušan Sokolović
BDBoris Djindjic
Boris Djindjic
JNJelenka Nikolic
Jelenka Nikolic
GBGordana Bjelakovic
Gordana Bjelakovic
DPDusica Pavlovic
Dusica Pavlovic
VPVoja Pavlovic
Voja Pavlovic
Purpose: The aim of the study was to evaluate the intensity of oxidative stress in the brain of animals chronically exposed to mobile phones and pote

28 May 2018 in Medicinal Research Reviews
Verified
Journal Article
Closed access
PDF file
KTKatarina Tomovic
Katarina Tomovic
JLJelena Lazarevic
Jelena Lazarevic
Gordana KocicGordana Kocic
Gordana Kocic
MDMarina Deljanin‐Ilic
Marina Deljanin‐Ilic
MAMarko Anderluh
Marko Anderluh
AŠAndrija Šmelcerović
Andrija Šmelcerović

11 September 2017 in Experimental and Clinical Endocrinology & Diabetes
Verified
Journal Article
Closed access
PDF file
AKAleksandra Klisic
Aleksandra Klisic
AIAleksandra Isakovic
Aleksandra Isakovic
Gordana KocicGordana Kocic
Gordana Kocic
NKNebojsa Kavaric
Nebojsa Kavaric
MJMilovan Jovanovic
Milovan Jovanovic
ANAna Ninic
Ana Ninic
Introduction/Aim Considering the high prevalence of non-alcoholic fatty liver disease (NAFLD) in individuals with type 2 diabetes mellitus (DM2), we aimed to investigate the potential benefit of determining markers of oxidative stress, inflammation and dyslipidemia for prediction of NAFLD, as estimated with fatty liver index (FLI) in individuals with DM2. Methods A total of 139 individuals with DM2 (of them 49.9% females) were enrolled in cross-sectional study. Anthropometric and biochemical parameters, as well as blood pressure were obtained. A FLI was calculated. Results Multivariate logistic regression analysis showed that high density lipoprotein cholesterol (HDL-c) and malondialdehyde (MDA) were independent predictors of higher FLI [Odds ratio (OR)=0.056, p=0.029; and OR=1.105, p=0.016, respectively]. In Receiver Operating Characteristic curve analysis, the addition of fatty liver risk factors (e. g., age, gender, body height, smoking status, diabetes duration and drugs metabolized in liver) to each analysed biochemical parameter [HDL-c, non-HDL-c, high sensitivity C-reactive protein (hsCRP), MDA and advanced oxidant protein products (AOPP)] in Model 1, increased the ability to discriminate patients with and without fatty liver [Area under the curve (AUC)=0.832, AUC=0.808, AUC=0.798, AUC=0.824 and AUC=0.743, respectively]. Model 2 (which included all five examined predictors, e. g., HDL-c, non-HDL-c, hsCRP, MDA, AOPP, and fatty liver risk factors) improved discriminative abilities for fatty liver status (AUC=0.909). Even more, Model 2 had the highest sensitivity and specificity (89.3% and 87.5%, respectively) together than each predictor in Model 1. Conclusion Multimarker approach, including biomarkers of oxidative stress, dyslipidemia and inflammation, could be of benefit in identifying patients with diabetes being at high risk of fatty liver disease.

1 June 2007 in Journal of Basic and Clinical Physiology and Pharmacology
Verified
Journal Article
Closed access
GBG. Bjelaković
G. Bjelaković
Simone BeninatiSimone Beninati
Simone Beninati
DPD. Pavlović
D. Pavlović
Gordana KocicGordana Kocic
Gordana Kocic
TJT. Jevtović
T. Jevtović
JBJelena Bašić
Jelena Bašić
Glucocorticoids (GC) are used widely for the treatment of patients with various disorders, including autoimmune diseases, allergies, and lymphoproliferative disorders. Glucocorticoid therapy is often limited by several adverse reactions associated with GC excess. Excess GC can elicit a variety of symptoms and signs, including growth retardation in children; immunosuppression; cardiovascular disorders like hypertension and atherosclerosis; osteoporosis; myopathy; and diabetes mellitus. Currently, attention is focused on oxidative stress as one of the major determinants of endothelial dysfunction and cardiovascular senescence. The main reason for all unwanted effects of GC is that dexamethasone induces the overproduction of reactive oxygen species, causing dysregulation of physiological processes. Humans and animals with GC-induced hypertension exhibit reduced nitric oxide levels; patients with excess GC levels also suffer from depression as a consequence of low levels of serotonin and melatonin. The common cofactor for the production of these vasoactive molecules is tetrahydrobiopterin (BH4), which is required for nitric oxide synthesis.

19 July 2016 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
BRBranislav Rovcanin
Branislav Rovcanin
BMBranislava Medic
Branislava Medic
Gordana KocicGordana Kocic
Gordana Kocic
TCTatjana Cebovic
Tatjana Cebovic
MRMarko Ristic
Marko Ristic
MPMilica Prostran
Milica Prostran
Ischemic reperfusion kidney injury (IRKI) is a complex pathophysiological event, which is the most common cause of the acute kidney injury. The key characteristic of IRKI is a reduction in glomerular filtration rate, which implies an underlying impairment in hemodynamic regulation. In recent decades, convincing evidence illuminated the molecular and pathological events in the acute kidney injury, revealing the role of ischemia/reperfusion, oxidative stress, apoptosis, inflammation, fibrosis and changes in gene expression which activate different signaling pathways. The cascade of inflammation events is a key mediator of IRKI, which includes the inflammation process, complement activation and mobilization of innate immunity. Oxidative stress represents the increased presence of various free radicals that cannot be buffered by the antioxidant capacity which comprises of enzymatic and non-enzymatic components. Renal tissue injury during ischemia/reperfusion comes as a result of membrane lipids peroxidation, oxidative damage of proteins and DNA and results in apoptosis and necrosis. It is evident from many studies that augmentation of the antioxidant defense mechanisms has a protective role on kidney tissue. In recent years, the importance of heat-shock proteins and MicroRNAs in the pathogenesis of IRKI has been revealed and there are promising indications that in future they could serve as diagnostic biomarkers or therapeutic targets. Striking changes in global gene expression were shown, providing a great potential for fundamental understanding and clinical management of IRKI. The clinical outcome among patients with kidney transplantation will have the furthermost advance from the better understanding of the underlying molecular pathology of IRKI.